Article citationsMore>>
Nakajima, A., Seki, M., Taniguchi, S., et al. (2018) Determining an Optimal Clinical Dose of Elobixibat, a Novel Inhibitor of the Ileal Bile Acid Transporter, in Japanese Patients with Chronic Constipation: A Phase II, Multicenter, Double-Blind, Placebo-Controlled Randomized Clinical Trial. Journal of Gastroenterology, 53, 525-534.
https://doi.org/10.1007/s00535-017-1383-5
has been cited by the following article: